Long-acting octreotide for the treatment and symptomatic relief of bowel obstruction in advanced ovarian cancer

Journal of Pain and Symptom Management

Volumn 30, Issue 6, 2005, Pages 563-569

  Matulonis, Ursula A ^a   Seiden, Michael V ^b   Roche, Maria ^b   Krasner, Carolyn ^b   Fuller, Arlan F ^b   Atkinson, Tina ^a   Kornblith, Alice ^a   Penson, Richard ^b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Bowel obstruction; Long acting octreotide; Ovarian cancer

Indexed keywords

ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; DIPHENHYDRAMINE; LIDOCAINE; LONG ACTING DRUG; OCTREOTIDE; PRILOCAINE;

ABDOMINAL CRAMP; ABDOMINAL PAIN; ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ADULT; AGED; ALKALINE PHOSPHATASE BLOOD LEVEL; ANAPHYLAXIS; ANTINEOPLASTIC ACTIVITY; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL FEATURE; CONSTIPATION; DRUG HYPERSENSITIVITY; DRUG SAFETY; DYSPEPSIA; DYSPNEA; FEMALE; FLATULENCE; GALLSTONE; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; HYPERTENSION; HYPOTENSION; INJECTION SITE PAIN; INTESTINE OBSTRUCTION; MYALGIA; OVARY CANCER; PILOT STUDY; QUALITY OF LIFE; THORAX PAIN; URTICARIA;

ADULT; AGED; ANTINEOPLASTIC AGENTS, HORMONAL; FEMALE; GASTROINTESTINAL AGENTS; HUMANS; INTESTINAL OBSTRUCTION; MIDDLE AGED; OCTREOTIDE; OVARIAN NEOPLASMS; PAIN; PALLIATIVE CARE; PILOT PROJECTS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 29244463854     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2005.05.018     Document Type: Article

References (28)

1. G.J. Beattie, R. Leonard, and J.F. Smyth Bowel obstruction in ovarian carcinoma: a retrospective study and review of the literature J Palliat Care 3 1989 275 280
2. J.C. Tunca, D.A. Buchler, and E.A. Mack The management of ovarian-cancer-caused bowel obstruction Gynecol Oncol 12 1981 186 192
3. M. Baines, D.J. Oliver, and R.L. Carter Medical management of intestinal obstruction in patients with advanced malignant disease: a clinical and pathological study Lancet 2 1985 990 993
4. P.M. Dvoretsky, K.A. Richards, and C. Angel Distribution of disease at autopsy in 100 women with ovarian cancer Hum Pathol 19 1988 57 63
5. D.J. Feuer, D.E. Broadley, J.H. Shepherd, and D.P.J. Barton Systemic review of surgery in malignant bowel obstruction in advanced gynecological and gastrointestinal surgery Gynecol Oncol 75 1999 313 322
6. A. Jatoi, K.C. Podratz, P. Gill, and L.C. Hartmann Pathophysiology and palliation of inoperable bowel obstruction in patients with ovarian cancer Support Oncol 2 2004 323 334
7. C. Ripamonti, C. Panzeri, L. Groff, G. Galeazzi, and R. Boffi The role of somatostatin and octreotide in bowel obstruction: pre-clinical and clinical results Tumori 87 2001 1 9
8. H.K. Wright, J.J. O'Brien, and M.D. Tilson Water absorption in experimental closed segment obstruction of the ileum in man Am J Surg 121 1971 96 99
9. R. Shields The absorption and secretion of fluid and electrolytes by the obstructed bowel Br J Surg 52 1965 774 779
10. M.S. Piver, J.J. Barlow, S.B. Lele, and A. Frank Survival after ovarian cancer induced intestinal obstruction Gynecol Oncol 13 1982 44 49
11. T.W. Castaldo, E.D. Petrilli, S.C. Ballon, and L.D. Lagasse Intestinal operations in patients with ovarian cancer Am J Obstet Gynecol 139 1981 80 84
12. C. Ripamonti, and E. Bruera Palliative management of malignant bowel obstruction Int J Gynecol Cancer 12 2002 135 143
13. S. Mercadante, P. Ferrera, P. Villari, and A. Marrazzo Aggressive pharmacological treatment for reversing malignant bowel obstruction J Pain Symptom Manage 28 2004 412 416
14. E. Tsahalina, R.P. Woolas, and P.G. Carter Gastrostomy tubes in patients with recurrent gynecological cancer and intestinal obstruction BJOG 106 1999 964 968
15. J. Rubin, J. Ajani, and W. Schirmer Octreotide acetate long-acting formulation versus open-label subcutaneous octreotide acetate in malignant carcinoid syndrome J Clin Oncol 17 1999 600 606
16. G. Mangili, M. Franchi, and A. Mariani Octreotide in the management of bowel obstruction in terminal ovarian cancer Gynecol Oncol 61 1996 345 348
17. S. Mercadante The role of octreotide in palliative care J Pain Symptom Manage 9 1994 406 411
18. S. Reichlin Medical progress: somatostatin N Engl J Med 309 1983 1495 1501
19. S. Reichlin Medical progress (Part 2) N Engl J Med 309 1983 1556 1563
20. M.T. Fallon The physiology of somatostatin and its synthetic analogue, octreotide Eur J Palliat Care 1 1994 20 22
21. Product insert, LAR octreotide.
22. C. Scarpignato, and I. Pelosini Somatostatin analogs for cancer treatment and diagnosis: an overview Chemotherapy 47 Suppl 2 2001 1 29
23. N.K. Aaronson, S. Ahmedzai, and B. Bergman The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology J Natl Cancer Inst 85 1993 365 376
24. A. Cull, S. Howat, and E. Greimel A development of the European Organization for Research and Treatment of Cancer Questionnaire module to assess the quality of life of ovarian cancer patients in clinical trials. A progress report Eur J Cancer 37 2001 47 53
25. J. Riley, and M.T. Fallon Octreotide in terminal bowel obstruction of the gastrointestinal tract Eur J Palliat Care 1 1994 23 28
26. K. Mystakidou, E. Tsilika, and O. Kalaidopoulou Comparison of octreotide administration versus conservative treatment in the management of inoperable bowel obstruction in patients with far advanced cancer: a randomized, double-blind, controlled study Anticancer Res 22 2002 1187 1192
27. R.H. Jones, J.-C. Reubi, D. Millan, and P. Vasey Octreotide: an active agent in epithelial ovarian carcinoma? Lancet Oncol 5 2004 251 253
28. C. Bousquet, E. Puente, L. Buscall, N. Vaysse, and C. Susini Antiproliferative effect of somatostatin and analogs Chemotherapy 47 Suppl 2 2001 30 39